Crystal structures of the multispecific 17β-hydroxysteroid dehydrogenase type 5: Critical androgen regulation in human peripheral tissues

Molecular Endocrinology

Volumn 18, Issue 7, 2004, Pages 1798-1807

  Qiu, Wei ^a   Zhou, Ming ^a   Labrie, Fernand ^a   Lin, Sheng Xiang ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PHENYLALANINE; TESTOSTERONE 17BETA DEHYDROGENASE; TRYPTOPHAN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; ENZYME STRUCTURE; ENZYME SUBSTRATE; HORMONE BINDING; PRIORITY JOURNAL; REGULATORY MECHANISM;

17-HYDROXYSTEROID DEHYDROGENASES; ANDROGENS; ANDROSTENEDIONE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HUMANS; MALE; MODELS, MOLECULAR; NADP; PHENYLALANINE; PROSTATE; PROTEIN CONFORMATION; TESTOSTERONE;

EID: 3042829462     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0032     Document Type: Article

References (50)

1. Adamski J, Jakob FJ 2001 A guide to 17β-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 171:1-4
2. Brereton P, Suzuki T, Sasano H, Li K, Duarte C, Obeyesekere V, Haeseleer F, Palczewski K, Smith I, Komesaroff P, Krozowski Z 2001 Pan1b (17β-HSD11)-enzymatic activity and distribution in the lung. Mol Cell Endocrinol 22:111-117
3. He XY, Merz G, Mehta P, Schulz H, Yang SY 1999 Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17β-hydroxysteroid dehydrogenase. J Biol Chem 274:15014-15019
4. Krazeisen A, Breitling R, Imai K, Fritz S, Moller G, Adamski J 1999 Determination of cDNA, gene structure and chromosomal localization of the novel human 17β-hydroxysteroid dehydrogenase type 7(1). FEBS Lett 29:373-379
5. Dufort I, Rheault P, Huang X-F, Soucy P, Luu-The V 1999 Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 140:1-7
6. Su J, Lin M, Napoli JL 1999 Complementary deoxyribonucleic acid cloning and enzymatic characterization of a novel 17β/3α-hydroxysteroid/ retinoid short chain dehydrogenase/reductase. Endocrinology 140:5275-5284
7. Fomitcheva J, Baker ME, Anderson E, Lee GY, Aziz N 1998 Characterization of Ke 6, a new 17β-hydroxysteroid dehydrogenase, and its expression in gonadal tissues. J Biol Chem 273:22664-22671
8. Li KX, Smith RE, Krozowski ZS 1998 Cloning and expression of a novel tissue specific 17β-hydroxysteroid dehydrogenase. Endocr Res 24:663-667
9. Nokelainen P, Peltoketo H, Vihko R, Vihko P 1998 Expression cloning of a novel estrogenic mouse 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol Endocrinol 12:1048-1059
10. Biswas MG, Russell DW 1997 Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate. J Biol Chem 272:15959-15966
11. Khanna M, Qin KN, Wang RW, Cheng KC 1995 Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J Biol Chem 270:20162-20168
12. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russel DW, Andersson S 1994 Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteoid dehydrogenase 3. Nat Genet 7:34-39
13. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S 1993 Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 α-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964-12969
14. Luu-The V, Labrie C, Zhao H-F, Couet J, Lachance Y, Simard J, Leblanc G, Labrie F 1989 Characterization of cDNAs for human estradiol 17β- dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Mol Endocrinol 3:1301-1309
15. Peltoketo H 1988 Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239:73-77
16. Peltoketo H, Luu-The V, Simard J, Adamski J 1999 17β-Hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 23:1-11
17. Ghosh D, Pletnev VZ, Zhu D-W, Wawrzak Z, Duax W-L, Pangborn W, Labrie F, Lin S-X 1995 Structure of human 17β-hydroxysteroid dehydrogenase at 2.20 resolution. Structure 3:503-513
18. Azzi A, Rehse PH, Zhu DW, Campbell RL, Labrie F, Lin S-X 1996 Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol. Nat Struct Biol 3:665-668
19. Breton R, Housset D, Mazza C, Fontecilla-Camps JC 1996 The structure of a complex of human 17β-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. Structure 4:905-915
20. Qiu W, Campbell RL, Gangloff A, Dupuis P, Boivin RP, Tremblay MR, Poirier D, Lin S-X 2002 A concerted, rational design of type 1 17β-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity. FASEB J 16:1829-1831
21. Petrow V 1986 The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. Prostate 9:343-361
22. Labrie F, Dupont A, Belanger A, Giguere M, Lacoursiere Y, Emond J, Monfette G, Bergeron V 1985 Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J Steroid Biochem 23:833-841
23. Crawford ED 1989 Combined androgen blockade. Urology 34:22-26
24. Labrie F, Belanger A, Cusan L, Labrie C, Simard J, Luu-The V, Diamond P, Gomez JL, Candas B 1996 History of LHRH agonist and combination therapy in prostate cancer. Endocr Rel Cancer 3:243-278
25. Labrie F, Luu-The V, Lin S-X, Simard J, Labrie C, El-Alfy M, Pelletier G, Belanger A 2000 Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. Mol Endocrinol 25:1-16
26. Labrie F 2003 Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 64:95-107
27. Kuhn-Velten WN 2000 Intracrinology and the local enzymatic control of hormone distribution and metabolism: dehydroepiandrosterone does not just act as a prohormone for androgens and estrogens. Eur J Clin Invest 3:34-38
28. Sasano H, Suzuki T, Harada N 1998 From endocrinology to intracrinology. Endocr Pathol 9:9-20
29. El-Alfy M, Luu-The V, Huang X-F, Berger L, Labrie F, Pelleter G 1999 Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology 140:1481-1491
30. Qin KN, Rosenfield RL 2000 Expression of 17β-hydroxysteroid dehydrogenase type 5 in human ovary: a pilot study. J Soc Gynecol Investig 7:61-64
31. Blouin K, Richard C, Belanger C, Dupont P, Daris M, Laberge P, Luu-The V, Tchernof A 2003 Local androgen inactivation in abdominal visceral adipose tissue. J Clin Endocrinol Metab 88:5944-5950
32. Labrie F, Luu-The V, Labrie C, Pelletier G, El-Alfy M 2000 Intracrinology and the skin. Horm Res 54:218-229
33. Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N 2001 Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 171:137-149
34. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K 2001 Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77
35. Farber GK, Petsko GA 1990 The evolution of α/β barrel enzymes. Trends Biochem Sci 15:228-234
36. Gangloff A, Shi R, Nahoum V, Lin S-X 2003 Pseudosymmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17β-hydroxysteroid dehydrogenase. FASEB J 17:274-276
37. Deleted in proof
38. Bennett MJ, Albert RH, Jez JM, Ma H, Penning TM, Lewis M 1997 Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3α-hydroxysteroid/dihydrodiol dehydrogenase. Structure 5:799-812
39. Nahoum V, Gangloff A, Legrand P, Zhu D-W, Cantin L, Zhorov BS, Luu-The V, Labrie F, Breton R, Lin S-X 2001 Structure of the human 3α-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25 A resolution. J Biol Chem 276:42091-42098
40. Couture JF, Legrand P, Cantin L, Luu-The V, Labrie F, Breton R 2003 Human 20α-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids. J Mol Biol 331:593-604
41. Penning TM, Burczynski ME, Jez JM, Lin H-K, Ma H, Moore M, Ratnam K, Palackal N 2001 Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 171:137-149
42. Hoog SS, Pawlowski JE, Alzari PM, Penning TM, Lewis M 1994 Three-dimensional structure of rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc Natl Acad Sci USA 91:2517-2521
43. Bennett MJ, Schlegel BP, Jez JM, Penning TM, Lewis M 1996 Structure of 3α-hydroxysteroid/dihdrodiol dehydrogenase complexed with NADP+. Biochemistry 35:10702-10711
44. Jin Y, Stayrook SE, Albert RH, Palackal NT, Penning TM, Lewis M 2001 Crystal structure of human type III 3α-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. Biochemistry 40:10161-10168
45. Zhou M, Qiu W, Chang H-J, Gangloff A, Lin S-X 2002 Purification, crystallization and preliminary x-ray diffraction results of human 17β-hydroxysteroid dehydrogenase type 5. Acta Crystallogr D 58:1048-1050
46. Otwinowski Z, Minor W 1997 Processing of x-ray diffraction data collected in osillation mode. Methods Enzymol 276:307-326
47. Kissinger CR, Gehlhaar DK. Fogel DB 1999 Rapid automated molecular replacement by evolutionary search. Acta Crystallogr D 55:484-491
48. Perrakis A, Morris R, Lamzin VS 1999 Automated protein model building combined with iterative structure refinement. Nat Struct Biol 6:458-463
49. Jones TA, Zou JY, Cowan SW, Kjeldgaard M 1991 Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110-119
50. Collaborative Computational Project Number 4 1994 The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 50:760-763